Exchange: NASDAQ·Updated 07:30 PM EDT
CTOR logo

CTOR Citius Oncology Inc.

$0.86
$0.0678
(8.56%)
Today
Closed $0.86
$0.00
(0.00%)
After Hours
Mkt Cap$73.66M
Vol54,788.00

About CTOR

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.
42

Bearish Sentiment

How do you feel about CTOR?

Advertisement|Remove ads.